Malanta has secured $10 million in seed funding led by Cardumen Capital to advance its innovative cybersecurity platform designed to prevent AI-driven cyberattacks.
Target Information
Malanta is a pioneering cybersecurity platform launched in 2025, focusing on preventing cyberattacks prior to their occurrence. With a recent funding round of $10 million led by Cardumen Capital, Malanta aims to provide organizations with enhanced visibility and control over potential threats, specifically from AI-driven attackers.
The company employs predictive intelligence to identify Pre-Attack Indicators (IoPA), which are digital fingerprints that cybercriminals leave before launching an attack. By collecting various pre-attack signals from across the internet, such as new domain registrations and developing phishing kits, Malanta seeks to neutralize AI attackers during their preparation phase, before an actual attack is executed.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
The rapid rise of artificial intelligence has empowered cyber adversaries, enabling them to automate the process of identifying and exploiting digital vulnerabilities within minutes. Traditional cybersecuri
Similar Deals
Ibtikar Fund and Flat6Labs Jordan Seed Fund → DataQueue
2025
Gluon Syndicate → Assista AI
2025
Cardumen Capital
invested in
Malanta
in 2025
in a Seed Stage deal
Disclosed details
Transaction Size: $10M